Importance: The best respiratory support technique to reduce intubation and mortality in patients with respiratory failure due to COVID-19 is controversial. Objective: To determine the respiratory support technique that could reduce the need for tracheal intubation and mortality in patients with respiratory failure due to COVID-19 admitted to intensive care units (ICUs) of Military’s Hospital (HIAOBO) in Gabon. Design, Setting, and Participants-Methodology: Prospective observational study over 10 months (January 2021-October 2021). We included patients admitted to intensive care for SARS Cov2 pneumonia who had benefited from available ventilatory support: high concentration face mask, High Flow Nasal cannula (HFNC), NIV (Non Invasive Ventilation), Continuous Positive Airway Pressure (CPAP). The choice was guided by the clinical condition, and the choice of the prescribing physicians. Recourse to mechanical ventilation was decided when faced with a Glasgow score of less than 13, an SpO2/FiO2 ratio ≤ 300, a FR ≥ 35/min, the impossibility of drainage of secretions. Main Outcomes and Measures: The primary outcome was the proportion of patients requiring intubation. The secondary outcomes were mortality in ICU. Results: The sample included 97 patients, the average age was55.6 years, hypertension was the main comorbidity (51.1%). Mean respiratory rate (RR) was 30.8 cycles/min, admission SpO2 was 83%, respiratory alkalosis was present in 63% of patients, mean CT involvement was 51%.Respiratory support was NIV (56.7%), CPAP (21.65%), high concentration face mask (18.55%). Sixteen percent (16%) of patients were intubated, 93% of them following failure of NIV. Mortality was 30%, mechanical ventilation was an independent risk factor for mortality. Conclusions: Non Invasive Ventilation, CPAP, and high-concentration face mask were frequently used in patients with COVID-related acute respiratory failure. The CPAP has reduced the need for intubation. Mechanical ventilation is a risk factor for death.
References
[1]
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., et al. (2020) Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. The Lancet Respiratory Medicine, 8, 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5
[2]
Murthy, S., Gomersall, C.D. and Fowler, R.A. (2020) Care for Critically Ill Patients with COVID-19. JAMA, 323, 1499-1500. https://doi.org/10.1001/jama.2020.3633
[3]
Alhazzani, W., Møller, M.H., Arabi, Y.M., Loeb, M., Gong, M.N., Fan, E., et al. (2020) Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine, 46, 854-887. https://doi.org/10.1007/s00134-020-06022-5
[4]
Rice, T.W., Wheeler, A.P., Bernard, G.R., et al. (2007) Comparison of the Spo2/Fio2 Ratio and the Pao2/Fio2 Ratio in Patients with Acute Lung Injury or ARDS. Chest, 132, 410-417. https://doi.org/10.1378/chest.07-0617
[5]
Franco, C., Facciolongo, N., Tonelli, R., et al. (2020) Feasibility and Clinical Impact of Out-of-ICU Non-Invasive Respiratory Support in Patients with COVID-19 Related Pneumonia. European Respiratory Journal, 56, 2002130. https://doi.org/10.1183/13993003.02130-2020
[6]
Tetaj, N., Piselli, P., Zito, S., De Angelis, G., Marini, M.C., Rubino, D., Gaviano, I., Antonica, M.V., Agostini, E., Porcelli, C., Stazi, G.V., Garotto, G., Busso, D., Scarcia, S., Navarra, A., Cimaglia, C., Topino, S., Iacomi, F., D’Abramo, A., Pinnetti, C., Gualano, G., Capone, A., Villanacci, A., Antinori, A., Palmieri, F., D’Offizi, G., Ianniello, S., Taglietti, F., Campioni, P., Vaia, F., Nicastri, E., Girardi, E., Marchioni, L. and on behalf of the ReCOVeRI Study Group (2022) Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital. Medicina, 58, 1104. https://doi.org/10.3390/medicina58081104
[7]
Ferreyro, B.L., Angriman, F., Munshi, L., et al. (2020) Association of Noninvasive Oxygenation Strategies with All-Cause Mortality in Adults with Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-Analysis. JAMA, 324, 57-67. https://doi.org/10.1001/jama.2020.9524
[8]
Ospina-Tascón, G.A., Calderón-Tapia, L.E., García, A.F., et al. (2021) HiFLo-Covid Investigators. Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients with Severe COVID-19: A Randomized Clinical Trial. JAMA, 326, 2161-2171. https://doi.org/10.1001/jama.2021.20714
[9]
D.L., Grieco, L.S., Menga, M., Cesarano, et al. (2021) Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure. The HENIVOT Randomized Clinical Trial. JAMA, 325, 1731-1743. https://doi.org/10.1001/jama.2021.4682
[10]
da Silva Costa, W.N., Miguel, J.P., Dos Santos Prado, F., de Mello Lula, L.H.S., Amarante, G.A.J., Righetti, R.F. and Yamaguti, W.P. (2022) Noninvasive Ventilation and High-Flow Nasal Cannula in Patients with Acute Hypoxemic Respiratory Failure by Covid-19: A Retrospective Study of the Feasibility, Safety and Outcomes. Respiratory Physiology & Neurobiology, 298, 103842. https://doi.org/10.1016/j.resp.2022.103842
[11]
Perkins, G.D., Chen, J., Connolly, B.A., et al. (2022) Effect of Noninvasive Respiratory Strategies on Intubation or Mortality among Patients with Acute Hypoxemic Respiratory Failure and COVID-19. The RECOVERY-RS Randomized Clinical Trial. JAMA, 327, 546-558. https://doi.org/10.1001/jama.2022.0028
[12]
Oranger, M., Gonzalez-Bermejo, J., Dacosta-Noble, P., et al. (2020) Continuous Positive Airway Pressure to Avoid Intubation in SARS-CoV-2 Pneumonia: A Two-Period Retrospective Case-Control Study. European Respiratory Journal, 56, 2001692. https://doi.org/10.1183/13993003.01692-2020
[13]
Faraone, A., Beltrame, C., Crociani, A., Carrai, P., Lovicu, E., Filetti, S., Sbaragli, S., Alessi, C., Smith, M.C., Angotti, C. and Fortini, A. (2020) Effectiveness and Safety of Noninvasive Positive Pressure Ventilation in the Treatment of COVID-19-Associated Acute Hypoxemic Respiratory Failure: A Single Center, Non-ICU Setting Experience. Internal and Emergency Medicine. https://doi.org/10.21203/rs.3.rs-73781/v1
[14]
Zanella, A., Florio, G., et al. (2021) Time Course of Risk Factors Associated with Mortality of 1260 Critically Ill Patients with COVID-19 Admitted to 24 Italian Intensive Care Units. Intensive Care Medicine, 47, 995-1008.
[15]
Vaschetto, R., Barone-Adesi, F., Racca, F., et al. (2021) Outcomes of COVID-19 Patients Treated with Continuous Positive Airway Pressure outside ICU. ERJ Open Research, 7, 00541.
[16]
Ding, L., Wang, L., Ma, W. and He, H. (2020) Efficacy and Safety of Early Prone Positioning Combined with HFNC or NIV in Moderate to Severe ARDS: A Multi-Center Prospective Cohort Study. Critical Care, 24, Article No. 28. https://doi.org/10.1186/s13054-020-2738-5
